Targeted therapies and clinical trials in ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/24/suppl_10/x59/6675171/mdt473.pdf
Reference37 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Cancer incidence and mortality in Europe, 2004;Boyle;Ann Oncol,2005
3. Recent progress in the diagnosis and treatment of ovarian cancer;Jelovac;CA Cancer J Clin,2011
4. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory;Kurman;Am J Surg Pathol,2010
5. Integrated genomic analyses of ovarian carcinoma;Nature,2011
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component;Molecules;2021-09-30
2. Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer;Journal of Experimental & Clinical Cancer Research;2020-03-23
3. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion;Journal of Ovarian Research;2018-11-19
4. Molecular mechanisms of drug resistance in ovarian cancer;Journal of Cellular Physiology;2018-01-04
5. Specific immunotherapy in ovarian cancer: a systematic review;Immunotherapy;2016-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3